Uri Kartoun
Research Subjects
Uri Kartoun has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Kenney Ng
Center for Computational Health, IBM Research , 314 Main St., Cambridge, MA 02142 , USA
6 shared publications- Kenney Ng
IBM Research
5 shared publications Rahul Aggarwal
Boston University
5 shared publicationsAdam Perer
Boston University CMU Yoonyoung Park IBM Massachusetts General Hospital
4 shared publications- Amit V. Khera
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA
4 shared publications Heng Luo
BenevolentAI
4 shared publications
Latest Publications
- Open Access
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Investigating the impact of steroid dependence on gastrointestinal surgical outcomes from UK Biobank
Although corticosteroids are an important treatment for inflammatory bowel disease (IBD) patients, many subjects develop dependence, leading to serious long-term side effects. We applied causal inference analyses to investigate the length of steroid use on reoperations in IBD patients. We identified subjects in the UK Biobank general practice dataset with at least one major GI surgery and followed them for at least 5 years to evaluate subsequent operations. We defined steroid dependence as at least 12 weeks of use (vs. acute steroid use) prior to baseline surgery. Of the 363 subjects included in our analyses, 163 (45%) were prescribed steroids on or before baseline surgery, and of these (N = 125 of 163, 77%) were dependent. Additional analyses for time-dependent data on prescriptions found a link between prescription length and reoperation. Among UC subjects with acute use, the odds of reoperation were significantly lower (OR: 0.32, 95% CI: 0.0–0.73). Steroid dependence resulted in a delay of reoperation (median 1.2 vs. 2.3 years, P = 0.01). Our findings indicate that long-term steroid use tends to increase the need for reoperation, whereas short-term use may reduce it.
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessInvestigating the impact of steroid dependence on gastrointestinal surgical outcomes from UK Biobank
Although corticosteroids are an important treatment for inflammatory bowel disease (IBD) patients, many subjects develop dependence, leading to serious long-term side effects. We applied causal inference analyses to investigate the length of steroid use on reoperations in IBD patients. We identified subjects in the UK Biobank general practice dataset with at least one major GI surgery and followed them for at least 5 years to evaluate subsequent operations. We defined steroid dependence as at least 12 weeks of use (vs. acute steroid use) prior to baseline surgery. Of the 363 subjects included in our analyses, 163 (45%) were prescribed steroids on or before baseline surgery, and of these (N = 125 of 163, 77%) were dependent. Additional analyses for time-dependent data on prescriptions found a link between prescription length and reoperation. Among UC subjects with acute use, the odds of reoperation were significantly lower (OR: 0.32, 95% CI: 0.0–0.73). Steroid dependence resulted in a delay of reoperation (median 1.2 vs. 2.3 years, P = 0.01). Our findings indicate that long-term steroid use tends to increase the need for reoperation, whereas short-term use may reduce it.
- Open Access
- 2 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 3 (3) , oead059
Exploring the link between Gilbert’s syndrome and atherosclerotic cardiovascular disease: insights from a subpopulation-based analysis of over one million individuals
Uri Kartoun, PhD, Akl C Fahed, MD, MPH, Shinwan Kany, MD, Pulkit Singh, BA, Shaan Khurshid, MD, MPH, Aniruddh P Patel, MD, Puneet Batra, PhD, Anthony Philippaki
- 2 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 3 (3) , oead059
Open AccessExploring the link between Gilbert’s syndrome and atherosclerotic cardiovascular disease: insights from a subpopulation-based analysis of over one million individuals
Uri Kartoun, PhD, Akl C Fahed, MD, MPH, Shinwan Kany, MD, Pulkit Singh, BA, Shaan Khurshid, MD, MPH, Aniruddh P Patel, MD, Puneet Batra, PhD, Anthony Philippaki
- 7 February 2023
- Published by Elsevier in Journal of Hepatology
- Vol. 79 (2) , e80-e81
Fairness metrics: Additional principles to consider for improving MELD
- 7 February 2023
- Published by Elsevier in Journal of Hepatology
- Vol. 79 (2) , e80-e81
Fairness metrics: Additional principles to consider for improving MELD
- Open Access
RMExplorer: A Visual Analytics Approach to Explore the Performance and the Fairness of Disease Risk Models on Population Subgroups
Disease risk models can identify high-risk patients and help clinicians provide more personalized care. However, risk models developed on one dataset may not generalize across diverse subpopulations of patients in different datasets and may have unexpected performance. It is challenging for clinical researchers to inspect risk models across different subgroups without any tools. Therefore, we developed an interactive visualization system called RMExplorer (Risk Model Explorer) to enable interactive risk model assessment. Specifically, the system allows users to define subgroups of patients by selecting clinical, demographic, or other characteristics, to explore the performance and fairness of risk models on the subgroups, and to understand the feature contributions to risk scores. To demonstrate the usefulness of the tool, we conduct a case study, where we use RMExplorer to explore three atrial fibrillation risk models by applying them to the UK Biobank dataset of 445,329 individuals. RMExplorer can help researchers to evaluate the performance and biases of risk models on subpopulations of interest in their data.
Open AccessRMExplorer: A Visual Analytics Approach to Explore the Performance and the Fairness of Disease Risk Models on Population Subgroups
Disease risk models can identify high-risk patients and help clinicians provide more personalized care. However, risk models developed on one dataset may not generalize across diverse subpopulations of patients in different datasets and may have unexpected performance. It is challenging for clinical researchers to inspect risk models across different subgroups without any tools. Therefore, we developed an interactive visualization system called RMExplorer (Risk Model Explorer) to enable interactive risk model assessment. Specifically, the system allows users to define subgroups of patients by selecting clinical, demographic, or other characteristics, to explore the performance and fairness of risk models on the subgroups, and to understand the feature contributions to risk scores. To demonstrate the usefulness of the tool, we conduct a case study, where we use RMExplorer to explore three atrial fibrillation risk models by applying them to the UK Biobank dataset of 445,329 individuals. RMExplorer can help researchers to evaluate the performance and biases of risk models on subpopulations of interest in their data.
- 20 July 2022
- Published by Elsevier in Journal of Hepatology
- Vol. 78 (3) , e98-e99
Towards optimally replacing the current version of MELD
- 20 July 2022
- Published by Elsevier in Journal of Hepatology
- Vol. 78 (3) , e98-e99
Towards optimally replacing the current version of MELD
- 3 May 2022
- Published by Springer Nature in Journal of Medical Systems
- Vol. 46 (6) , 1-3
Memory-memory (M2) Authentication
The article introduces a new type of an authentication technique denoted as memory-memory (M2). A core component of M2 is its ability to collect and populate a voice profile database and use it to perform the verification process. The method relies on a database that includes voice profiles in the form of audio recordings of individuals; the profiles are interconnected based on known relationships between people such that relationships can be used to determine which voice profiles to select to test a person’s knowledge of the identity of the people in the recordings (e.g., their names, their relation to each other). Combining widely known concepts (e.g., humans are superior to computers in processing voices and computers are superior to humans in handling data) expects to significantly enhance existing authentication methods (e.g., passwords, biometrics-based).
- 3 May 2022
- Published by Springer Nature in Journal of Medical Systems
- Vol. 46 (6) , 1-3
Memory-memory (M2) Authentication
The article introduces a new type of an authentication technique denoted as memory-memory (M2). A core component of M2 is its ability to collect and populate a voice profile database and use it to perform the verification process. The method relies on a database that includes voice profiles in the form of audio recordings of individuals; the profiles are interconnected based on known relationships between people such that relationships can be used to determine which voice profiles to select to test a person’s knowledge of the identity of the people in the recordings (e.g., their names, their relation to each other). Combining widely known concepts (e.g., humans are superior to computers in processing voices and computers are superior to humans in handling data) expects to significantly enhance existing authentication methods (e.g., passwords, biometrics-based).
- 1 December 2021
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 33 (1S) , e1081
Beyond sodium: additional covariates to possibly enhance MELD
- 1 December 2021
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 33 (1S) , e1081
Beyond sodium: additional covariates to possibly enhance MELD
- Open Access
- 8 October 2021
- Published by Springer Nature in Research Square
Characterizing and Quantifying Performance Heterogeneity in Cardiovascular Risk Prediction Models — A Step Towards Improved Disease Risk Assessment
Prediction models are commonly used to estimate risk for cardiovascular diseases; however, performance may vary substantially across relevant subgroups of the population. Here we investigated the variability of performance and fairness across a variety of subgroups for risk prediction of two common diseases, atherosclerotic cardiovascular disease (ASCVD) and atrial fibrillation (AF). We calculated the Cohorts for Heart and Aging in Genomic Epidemiology Atrial Fibrillation (CHARGE-AF) for AF and the Pooled Cohort Equations (PCE) score for ASCVD in three large data sets: Explorys Life Sciences Dataset (Explorys, n = 21,809,334), Mass General Brigham (MGB, n = 520,868), and the UK Biobank (UKBB, n = 502,521). Our results demonstrate important performance heterogeneity of established cardiovascular risk scores across subpopulations defined by age, sex, and presence of preexisting disease. For example, in CHARGE-AF, discrimination declined with increasing age, with concordance index of 0.72 [ 95% CI, 0.72–0.73 ] for the youngest (45–54y) subgroup to 0.57 [ 0.56–0.58 ], for the oldest (85–90y) subgroup in Explorys. The statistical parity difference (i.e., likelihood of being classified as high risk) was considerable between males and females within the 65–74y subgroup with a value of -0.33 [ 95% CI, -0.33–-0.33 ]. We observed also that large segments of the population suffered from both decreased discrimination (i.e., <0.7) and poor calibration (i.e., calibration slope outside of 0.7–1.3); for example, all individuals 75 or older in Explorys (17.4%). Our findings highlight the need to characterize and quantify how clinical risk models behave and perform within specific subpopulations so they can be used appropriately to facilitate more accurate and equitable assessment of disease risk.
- 8 October 2021
- Published by Springer Nature in Research Square
Open AccessCharacterizing and Quantifying Performance Heterogeneity in Cardiovascular Risk Prediction Models — A Step Towards Improved Disease Risk Assessment
Prediction models are commonly used to estimate risk for cardiovascular diseases; however, performance may vary substantially across relevant subgroups of the population. Here we investigated the variability of performance and fairness across a variety of subgroups for risk prediction of two common diseases, atherosclerotic cardiovascular disease (ASCVD) and atrial fibrillation (AF). We calculated the Cohorts for Heart and Aging in Genomic Epidemiology Atrial Fibrillation (CHARGE-AF) for AF and the Pooled Cohort Equations (PCE) score for ASCVD in three large data sets: Explorys Life Sciences Dataset (Explorys, n = 21,809,334), Mass General Brigham (MGB, n = 520,868), and the UK Biobank (UKBB, n = 502,521). Our results demonstrate important performance heterogeneity of established cardiovascular risk scores across subpopulations defined by age, sex, and presence of preexisting disease. For example, in CHARGE-AF, discrimination declined with increasing age, with concordance index of 0.72 [ 95% CI, 0.72–0.73 ] for the youngest (45–54y) subgroup to 0.57 [ 0.56–0.58 ], for the oldest (85–90y) subgroup in Explorys. The statistical parity difference (i.e., likelihood of being classified as high risk) was considerable between males and females within the 65–74y subgroup with a value of -0.33 [ 95% CI, -0.33–-0.33 ]. We observed also that large segments of the population suffered from both decreased discrimination (i.e., <0.7) and poor calibration (i.e., calibration slope outside of 0.7–1.3); for example, all individuals 75 or older in Explorys (17.4%). Our findings highlight the need to characterize and quantify how clinical risk models behave and perform within specific subpopulations so they can be used appropriately to facilitate more accurate and equitable assessment of disease risk.
- Top Cited Papers
- 10 August 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (6) , 410-422
Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals
Background: Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disease compared with most other ethnicities. US practice guidelines now recognize South Asian ancestry as an important risk-enhancing factor. The magnitude of enhanced risk within the context of contemporary clinical care, the extent to which it is captured by existing risk estimators, and its potential mechanisms warrant additional study. Methods: Within the UK Biobank prospective cohort study, 8124 middle-aged participants of South Asian ancestry and 449 349 participants of European ancestry who were free of atherosclerotic cardiovascular disease at the time of enrollment were examined. The relationship of ancestry to risk of incident atherosclerotic cardiovascular disease—defined as myocardial infarction, coronary revascularization, or ischemic stroke—was assessed with Cox proportional hazards regression, along with examination of a broad range of clinical, anthropometric, and lifestyle mediators. Results: The mean age at study enrollment was 57 years, and 202 405 (44%) were male. Over a median follow-up of 11 years, 554 of 8124 (6.8%) individuals of South Asian ancestry experienced an atherosclerotic cardiovascular disease event compared with 19 756 of 449 349 (4.4%) individuals of European ancestry, corresponding to an adjusted hazard ratio of 2.03 (95% CI, 1.86–2.22; P 2-fold higher observed risk, the predicted 10-year risk of cardiovascular disease according to the American Heart Association/American College of Cardiology Pooled Cohort equations and QRISK3 equations was nearly identical for individuals of South Asian and European ancestry. Adjustment for a broad range of clinical, anthropometric, and lifestyle risk factors led to only modest attenuation of the observed hazard ratio to 1.45 (95% CI, 1.28–1.65, P <0.001). Assessment of variance explained by 18 candidate risk factors suggested greater importance of hypertension, diabetes, and central adiposity in South Asian individuals. Conclusions: Within a large prospective study, South Asian individuals had substantially higher risk of atherosclerotic cardiovascular disease compared with individuals of European ancestry, and this risk was not captured by the Pooled Cohort Equations.
- 10 August 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (6) , 410-422
Top Cited PapersQuantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals
Background: Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disease compared with most other ethnicities. US practice guidelines now recognize South Asian ancestry as an important risk-enhancing factor. The magnitude of enhanced risk within the context of contemporary clinical care, the extent to which it is captured by existing risk estimators, and its potential mechanisms warrant additional study. Methods: Within the UK Biobank prospective cohort study, 8124 middle-aged participants of South Asian ancestry and 449 349 participants of European ancestry who were free of atherosclerotic cardiovascular disease at the time of enrollment were examined. The relationship of ancestry to risk of incident atherosclerotic cardiovascular disease—defined as myocardial infarction, coronary revascularization, or ischemic stroke—was assessed with Cox proportional hazards regression, along with examination of a broad range of clinical, anthropometric, and lifestyle mediators. Results: The mean age at study enrollment was 57 years, and 202 405 (44%) were male. Over a median follow-up of 11 years, 554 of 8124 (6.8%) individuals of South Asian ancestry experienced an atherosclerotic cardiovascular disease event compared with 19 756 of 449 349 (4.4%) individuals of European ancestry, corresponding to an adjusted hazard ratio of 2.03 (95% CI, 1.86–2.22; P 2-fold higher observed risk, the predicted 10-year risk of cardiovascular disease according to the American Heart Association/American College of Cardiology Pooled Cohort equations and QRISK3 equations was nearly identical for individuals of South Asian and European ancestry. Adjustment for a broad range of clinical, anthropometric, and lifestyle risk factors led to only modest attenuation of the observed hazard ratio to 1.45 (95% CI, 1.28–1.65, P <0.001). Assessment of variance explained by 18 candidate risk factors suggested greater importance of hypertension, diabetes, and central adiposity in South Asian individuals. Conclusions: Within a large prospective study, South Asian individuals had substantially higher risk of atherosclerotic cardiovascular disease compared with individuals of European ancestry, and this risk was not captured by the Pooled Cohort Equations.
- 30 March 2021
- Published by Springer Nature in Journal of Medical Systems
- Vol. 45 (5) , 1-4
Enhancing Clinical Prediction Performance by Incorporating Intuition
- 30 March 2021
- Published by Springer Nature in Journal of Medical Systems
- Vol. 45 (5) , 1-4
Enhancing Clinical Prediction Performance by Incorporating Intuition